Imatinib Mesylate is Effective for Patients Not Only with Chronic Myeloid Leukemia, but Also Rheumatoid Arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imatinib Mesylate is Effective for Patients Not Only with Chronic Myeloid Leukemia, but Also Rheumatoid Arthritis

Published:2012 Issue:3 Volume:83 Page:405
ISSN:1738-9364
Container-title:Korean Journal of Medicine
language:ko
Short-container-title:Korean J Med

Author:

Jung Hyun Jun¹,Kim Dae Ho¹,Song Ran¹,Hong Seung-Jae²,Yang Hyung-In¹,Eo Wan Kyu¹,Lee Sang-Hoon¹

Affiliation:

1. Department of Internal Medicine, Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea.

2. Department of Internal Medicine, Kyung Hee University School of Medicine, Kyung Hee University Medical Center, Seoul, Korea.

Publisher

Korean Association of Internal Medicine

Subject

General Economics, Econometrics and Finance

Link

http://synapse.koreamed.org/pdf/10.3904/kjm.2012.83.3.405

Reference10 articles.

1. Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemia

2. Tyrosine Phosphorylated Proteins in Synovial Cells of Rheumatoid Arthritis

3. Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy

4. Imatinib mesylate induces clinical remission in rheumatoid arthritis

5. Efficacy of Imatinib Mesylate Treatment for a Patient with Rheumatoid Arthritis and Who Developed Chronic Myelogenous Leukemia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP